Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) Investor Alert: Lawsuit Against Takeover Filed
An investor, who currently holds shares of Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), filed a lawsuit in effort to halt the proposed takeover of Optimer Pharmaceuticals, Inc. by Cubist Pharmaceuticals, Inc.
View full press release